HCA Health Inc vs TJX Companies Inc — how do they compare? HCA Health Inc trades at $446.4 (market cap $96.35B), while TJX Companies Inc trades at $138.26 (market cap $152.62B). The key difference: TJX Companies Inc is the larger of the two by market cap, and TJX Companies Inc pays the higher dividend (1.38%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and TJX Companies Inc for 97 Days on average.
| HCA | TJX | |
|---|---|---|
Market Cap | $96.35B | $152.62B |
Volume | 1,079,453 | 8,079,794 |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $168.41 |
52-Week Low | $361.32 | $122.84 |
Typical Hold Time | 76 Days | 97 Days |
Enterprise Value | $146.88B | $160.93B |
Dividend Yield | 0.7% | 1.38% |
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.
The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.
TJX trades at $138.80, up 1.28% today, with a bullish technical trend and strong fundamentals. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.33. Revenue grew to $56.36B in 2025, with a net income margin of 8.63%. Analysts are overwhelmingly bullish, with an 84.9% buy rating and a consensus price target of $174.15, implying 25% upside. Recent news highlights TJX's value proposition and merchandising strength in the off-price retail sector.
TJX presents a compelling investment opportunity driven by earnings growth, high profitability (ROE 62.17%), and positive analyst sentiment. Risks include competitive pressures, economic sensitivity, and valuation multiples above industry averages. The stock's momentum and fundamental strength support a favorable outlook, but investors should monitor execution against future earnings expectations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →